Skip to main content
. 2019 Jun 16;55(6):279. doi: 10.3390/medicina55060279

Table 4.

Schematic representation of the number of skin cancers developed by our cohort of patients during follow-up.

Patients Total
N. of Tumors M (%) F (%) N (%)
0 221 (66.6) 149 (80.1) 370 (71.4)
1 53 (16.0) 24 (12.9) 77 (14.9)
2 23 (6.9) 8 (4.3) 31 (6.0)
3 19 (5.7) 2 (1.1) 21 (4.0)
4 16 (4.8) 3 (1.6) 19 (3.7)
Total 332 (100) 186 (100) 518 (100)

M = male; F = female.